Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
IL-5 and granulocyte macrophage-colony-stimulating factor (GM-CSF) are important regulators of eosinophil survival, proliferation, and effector function. To determine whether IL-5 and/or GM-CSF are generated by eosinophils at sites of allergic inflammation, we have used in situ hybridization with 35S-labeled RNA probes to study the expression of IL-5 and GM-CSF mRNA in bronchoalveolar lavage (BAL) eosinophils derived from asthmatics (n = 5) before and after endobronchial allergen challenge. Endobronchial allergen challenge induced a significant airway eosinophilia (pre-allergen challenge 0.6 +/- 0.5% eosinophilia vs post-allergen challenge 48.2 +/- 25.6% eosinophilia). Post-allergen challenge eosinophils expressed IL-5 and GM-CSF mRNA, but did not express IL-1 beta or IL-2 mRNA. To determine whether the IL-5 mRNA-positive cells coexpressed GM-CSF mRNA, double mRNA labeling experiments with a digoxigenin-11-UTP nonradioactive labeled IL-5 RNA probe and a GM-CSF 35S-labeled RNA probe were performed. These studies demonstrated that individual eosinophils expressed one of four cytokine mRNA profiles (IL-5+, GM-CSF+, 34 +/- 13%; IL-5+, GM-CSF-, 34 +/- 5%; IL-5-, GM-CSF+, 11 +/- 9%; IL-5-, GM-CSF-, 21 +/- 25%). The expression of IL-5 and GM-CSF by eosinophils at sites of allergic inflammation in asthmatics may provide an important autocrine pathway, maintaining the viability and effector function of the recruited eosinophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant human interleukin 5 is a selective activator of human eosinophil function.
Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G., & Vadas, M. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.1.219 · Cited by 951
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.
Hamid, Q., Azzawi, M., Ying, S., Moqbel, R., Wardlaw, A. J., Corrigan, C. J., Bradley, B., Durham, S. R., Collins, J. V., & Jeffery, P. K. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115166 · Cited by 833
Kay, A. B., Ying, S., Varney, V, Gaga, M., Durham, S. R., Moqbel, R., Wardlaw, A. J., & Hamid, Q. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.775 · Cited by 659
The Immunobiology of Eosinophils
Flier, J. S., Underhill, L. H., & Weller, P. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241607 · Cited by 635
Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J. S., & Gleich, G. J. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.745 · Cited by 334
Silberstein, D. S., Owen, W. F., Gasson, J. C., DiPersio, J. F., Golde, D. W., Bina, J. C., Soberman, R., Austen, K. F., & David, J. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.10.3290 · Cited by 272
Firestein, G. S., Paine, M. M., & Littman, B. H. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340905 · Cited by 257
Self-citationDesreumaux, P., Janin, A., Colombel, J. F., Prin, L., Plumas, J., Emilie, D., Torpier, G., Capron, A., & Capron, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.293 · Cited by 239
Moqbel, R., Hamid, Q., Ying, S., Barkans, J., Hartnell, A., Tsicopoulos, A., Wardlaw, A. J., & Kay, A. B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.749 · Cited by 197
Ohno, I., Lea, R. G., Finotto, S., Marshall, J. S., Denburg, J. A., Dolovich, J., Gauldie, J., & Jordana, M. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/5.6.505 · Cited by 101
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702
“The biological properties of eosinophils include the release of toxic granule proteins, oxygen free radicals, eicosanoids (sulfido-peptide leukotrienes) (168), Th 2 -like cytokines (169, 170), and growth factors (107, 171).”
BackgroundThe idiopathic hypereosinophilic syndrome
Weller, P., & Bubley, G. (1994) · Blood · doi:10.1182/blood.v83.10.2759.2759 · Cited by 929
Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H., & Holgate, S. T. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179909 · Cited by 830
Corry, D. B., Folkesson, H. G., Warnock, M. L., Erle, D. J., Matthay, M. A., Wiener-Kronish, J. P., & Locksley, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.109 · Cited by 722
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Zhang, D.-H., Cohn, L., Ray, P., Bottomly, K., & Ray, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21597 · Cited by 665
Collins, P. D., Marleau, S., Griffiths-Johnson, D. A., Jose, P. J., & Williams, T. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1169 · Cited by 658
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
Inhibition of airway remodeling in IL-5–deficient mice
Cho, J. Y., Miller, M., Baek, K. J., Han, J. W., Nayar, J., Lee, S. Y., McElwain, K., McElwain, S., Friedman, S., & Broide, D. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19133 · Cited by 377
Self-citationEosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity
Davoine, F., & Lacy, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00570 · Cited by 353
Pharmacology of the Eosinophil
Giembycz, M. A., & Lindsay, M. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01404-2 · Cited by 351
Leung, D. Y., Martin, R. J., Szefler, S. J., Sher, E. R., Ying, S., Kay, A. B., & Hamid, Q. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.33 · Cited by 348
Robinson, D., Hamid, Q., Ying, S., Bentley, A., Assoufi, B., Durham, S., & Kay, A. B. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.2.401 · Cited by 297
Immunological Aspects of Allergic Asthma
Bochner, B. S., Undem, B. J., & Lichtenstein, L. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001455 · Cited by 294
Dubucquoi, S., Desreumaux, P., Janin, A., Klein, O., Goldman, M., Tavernier, J., Capron, A., & Capron, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.703 · Cited by 291
Overview on the pathomechanisms of allergic rhinitis
Pawankar, R., Mori, S., Ozu, C., & Kimura, S. (2011) · Asia Pacific Allergy · doi:10.5415/apallergy.2011.1.3.157 · Cited by 280
“Mature eosinophils contain MBP [38], ECP [39], eosinophil-derived neurotoxin (EDN) [40], eosinophil peroxidase all of which play important roles in the immune mechanisms of allergic inflammation, especially in altering the surface epithelium.”
BackgroundTh2 Cytokine mRNA Expression in Skin in Cutaneous T-Cell Lymphoma
Vowels, B. R., Lessin, S. R., Cassin, M., Jaworsky, C., Benoit, B., Wolfe, J. T., & Rook, A. H. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12398454 · Cited by 263
The mechanism of IL-5 signal transduction
Adachi, T., & Alam, R. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.3.c623 · Cited by 242
“Once eosinophils infiltrate airways, they produce IL-5, establishing a positive feedback mechanism (12, 26).”
BackgroundKumagai, K., Ohno, I., Okada, S., Ohkawara, Y., Suzuki, K., Shinya, T., Nagase, H., Iwata, K., & Shirato, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4212 · Cited by 212
Current concepts of severe asthma
Ray, A., Raundhal, M., Oriss, T. B., Ray, P., & Wenzel, S. E. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84144 · Cited by 207
Gene expression of the GATA-3 transcription factor is increased in atopic asthma
Nakamura, Y., Ghaffar, O., Olivenstein, R., Taha, R. A., Soussi-Gounni, A., Zhang, D.-H., Ray, A., & Hamid, Q. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70493-8 · Cited by 206
Molecular pathology of allergic disease
Hamid, Q. A., & Minshall, E. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90172-6 · Cited by 196
Kinetics of Allergen-Induced Airway Eosinophilic Cytokine Production and Airway Inflammation
GAUVREAU, G. M., WATSON, R. M., & O'BYRNE, P. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9809130 · Cited by 190
“Furthermore, the data supports the notion that cooperation between chemokines may be necessary to induce eosinophil accumulation in vivo, as suggested in the guinea pig model of Gauvreau, Watson, and O’Byrne: Allergen-Induced Airway Inflammation 647 intradermal injection ( 37 ).”
BackgroundMould, A. W., Ramsay, A. J., Matthaei, K. I., Young, I. G., Rothenberg, M. E., & Foster, P. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2142 · Cited by 180
Desreumaux, P., Bloget, F., Seguy, D., Capron, M., Cortot, A., Colombel, J., & Janin, A. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608886 · Cited by 162
Metadata
- Authors
- Broide, D. H., Paine, M. M., & Firestein, G. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-10-01
- Volume
- 90
- Issue
- 4
- Pages
- 1414-1424
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2003528700
- Cited by
- 354
- References
- 11
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.